|
Written by bioXplorer
|
-
Family History Raises Breast Cancer Risk Despite Absence Of BRCA Mutations, Study Finds
Women with a strong family history of breast cancer have a four times greater risk for the disease than women in the general population, even if they do not carry a mutation of the BRCA gene, according to a study presented Monday at the American Association for Cancer Research's annual
-
Invitrogen Launches In Vivo RNAi Delivery Reagent - Products To Simplify And Enable Research On All Sequencing Platforms
Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced the introduction of its Invivofectamine™ delivery reagent which enables short interference ribonucleic acid (siRNA) experiments in vivo. The study of RNA interference (RNAi) has revolutionized biology by allowing researchers to directly observe the effects of the loss of function of specific genes in mammalian systems.
-
TaconicArtemis Announces Publication In PNAS: Inducible Gene Silencing In Transgenic Rats Via RNAi
TaconicArtemis GmbH, a subsidiary of Taconic today announced the publication of a scientific breakthrough achieved in a collaboration with the Universities Goettingen and Wuerzburg (Germany). For the first time it is now possible to inactivate disease-related genes in an inducible and reversible fashion in transgenic rats as rodent model organisms.
-
Stem Cell Pilot Study Tackles Devastating Genetic Paraplegia
BRISBANE'S National Centre for Adult Stem Cell Research will commence a pilot study into a devastating genetic disease in which active young people progressively develop paraplegia. The little-known disease, Hereditary Spastic Paraplegia, has about 1000 diagnosed sufferers in Australia, but the mutations responsible may lurk in the genes of an unknown percentage of the population.
-
Who Owns Your Genes? Expert Debate At National Scientific Meeting
Genetic science's potential to save lives may be compromised by anachronistic patent laws, according to a leading genetic cancer specialist and a patents lawyer who will make their case at a groundbreaking debate in Sydney today (20/11).
-
Technology May Provide Means Of Testing Anti-Aging Drugs
Scientists at the Buck Institute for Age Research have identified for the first time biomarkers of aging which are highly predictive of both chronological and physiological age. Biomarkers are biochemical features that can be used to measure the progress of disease or the effects of treatment. The research involves nematode worms, microarrays which measure changes in gene expression, and complex computer algorithms.
-
Janet Rossant To Deliver Annual Dame Anne McLaren Memorial Lecture - National Stem Cell Network
The UK National Stem Cell Network (UKNSCN) has announced that Professor Janet Rossant, one of the world's foremost developmental biologists from The Hospital for Sick Children in Toronto, will deliver the second annual Dame Anne McLaren Memorial Lecture. The Lecture is the principal keynote address of the UKNSCN's annual research conference, being next year in Oxford, 6-8 April.
-
GEN Reports On The Trend Toward Predictive Toxicogenomics
Biotech scientists increasingly are applying genomics technologies to toxicology research to better understand the effects of novel drug candidates on a variety of organ systems, reports Genetic Engineering & Biotechnology News (GEN). They are especially interested in figuring out a new compound's mechanism of action and eventually developing a predictive toxicology technique, according to the November 15 issue of GEN.
-
ADHD Medications Do Not Cause Genetic Damage In Children
In contrast to recent findings, two of the most common medications used to treat attention deficit hyperactivity disorder (ADHD) do not appear to cause genetic damage in children who take them as prescribed, according to a new study by researchers at the National Institutes of Health (NIH) and Duke University Medical Center.
-
Genetic Testing For Diabetes Type 2 Still In Its Infancy
Genetic testing for type 2 diabetes is still in its infancy, said researchers who did a US study that compared risk assessment based on screening for gene variants with more traditional risk factors like weight, blood pressure and blood sugar.
|
|
|
<< Start < Previous 1 2 3 4 5 6 7 8 9 10 Next > End >>
|
| Results 7 - 7 of 10 |
Latest News 
